0001847345 EX-FILING FEES 0001847345 2026-02-17 2026-02-17 0001847345 1 2026-02-17 2026-02-17 0001847345 2 2026-02-17 2026-02-17 0001847345 3 2026-02-17 2026-02-17 iso4217:USD xbrli:shares iso4217:USD xbrli:shares xbrli:pure

Exhibit 107

Calculation of Filing Fee Tables

S-1

(Form Type)

ASPIRE BIOPHARMA HOLDINGS, INC.

(Exact Name of Registrant as Specified in its Charter)

Table 1: Newly Registered and Carry Forward Securities

|  | Security Type |  |  | Security Class Title |  | Fee Calculation or Carry Forward Rule |  |  | Amount Registered |  |  | Proposed Maximum Offering Price Per Unit |  |  | Maximum Aggregate Offering Price (1) |  |  | Fee Rate |  |  | Amount of Registration Fee (3) |  |  | Carry Forward Form Type |  |  | Carry Forward File Number |  |  | Carry Forward Initial Effective Date |  |  | Filing Fee Previously Paid in Connection with Unsold Securities to be Carried Forward |
Newly Registered Securities |
Fees to be Paid |  |  | Equity |  |  | Common Stock, $0.001 par value per share |  |  | Rule 457(c) |  |  |  | 159,090,906 |  |  |  | 1.31 | (4) |  | $ | 208,409,086 | (4) |  | $ | 0.00013810 |  |  | $ | 28,781.29 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fees to be Paid |  |  | Equity |  |  | Series A Convertible Preferred Stock (2) |  |  | Rule 457(c) |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fees to be Paid |  |  | Equity |  |  | Common Stock, issuable upon the conversion of the Series A Convertible Preferred Stock |  |  | Rule 457(c) |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Fees Previously Paid |  |  | — |  |  | — |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Carry Forward Securities |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Carry Forward Securities |  |  | — |  |  | — |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |  |  |  | — |
Total Offering Amounts |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 208,409,086 |  |  | $ | 0.00013810 |  |  | $ | 28,781.29 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total Fees Previously Paid |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Total Fee Offset |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | — |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |
Net Fee Due |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  | $ | 28,781.29 |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |  |

(1) | Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) under the Securities Act of 1933, as amended (the “Securities Act”). Represents only the additional number of shares being registered. This does not include the securities that the Registrant previously registered on the Registration Statement on Form S-1.
(2) | No separate fee is required pursuant to Rule 457(g) under the Securities Act.
(3) | The registration fee is calculated in accordance with Rule 457(a) under the Securities Act of 1933, as amended, or the Securities Act, based on the proposed maximum aggregate offering price.
(4) | The Price per share used to obtain the maximum offering amount of such Common Stock for the purposes of calculating the registration fee was the average of the high and low trading prices of the Company’s Common Stock reported by Nasdaq on February 13, 2026, which was $1.31.

N/A